Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Incidence and outcome of post-transplant haemorrhagic cystitis in patients who undergo allogeneic haematopoietic cell transplantation

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION AS FIRST TRANSPLANT AFTER CHECKPOINT INHIBITORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN’S LYMPHOMA

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Carmen Martínez

Survey on the organization and techniques of ATMP facilities by DARE-NL, EBMT, T2Evolve, and NXTGEN-HIGHTECH - a GoCART-coalition initiative

Toutes les maladies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Thérapie génique

Thérapies cellulaires (autres que DLI)

Investigateur principal

Survey on ICU organization and ICU admission after haematopoietic cell transplantation with special emphasis on infectious causes

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Joanna Drozd-Sokolowska

Comparison of allogeneic hematopoietic stem cell transplantation (HCT) with CAR T-cells in relapsed and refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma (PMBCL)

Études rétrospectives

Lymphome non hodgkinien (LNH)

GoCART Coalition

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Infections following CAR-T therapy. A retrospective collaborative study between the Infectious Diseases Working Party (IDWP), the Cellular Therapy and Immunobiology Working Party (CTIWP), the Transplant Complications Working Party (TCWP) of the EBMT, the European Hematology Association (EHA), and the Medical College of Wisconsin.

Lymphome non hodgkinien (LNH)

Leucémie Aiguë Lymphoblastique (LAL)

GoCART Coalition

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Patterns and treatments of relapse after commercial use of anti-CD19 CART therapy in patients with relapsed/refractory diffuse large B cell lymphoma

Études rétrospectives

Lymphome non hodgkinien (LNH)

GoCART Coalition

Type de traitement

Investigateur principal

Alberto Mussetti

Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, CTIWP and TCWP

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Myélome multiple (MM) ou autre dyscrasies plasmocytaires (PCD)

Lymphome non hodgkinien (LNH)

GoCART Coalition

Autoimmune Diseases Working Party (ADWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Impact of Preceding Therapy of CART Cells in B-ALL and impact of consolidative HCT following complete remission post CART

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

GoCART Coalition

Type de traitement

Investigateur principal

Valentín ORTIZ-MALDONADO

Practice patterns of holding and bridging therapy for mantle cell lymphoma patients in the CAR T-cell setting

Closed Survey/Study

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Gloria Iacoboni, MD, PhD, Pere Barba, MD, PhD

Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP)

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Friedrich Stoelzel

Thrombotic microangiopathy (TMA) after CAR-T cell therapy

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Guillaume Dachy